NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Subcutaneous Calcitonin in Acute Herpes Zoster
Subcutaneous Calcitonin in Acute Herpes Zoster
RecruitingPhase 3
Sponsor: Tanta University
Conditions: Calcitonin, Subcutaneous, Acute Herpes Zoster
Interventions: Calcitonin, Saline
Countries: Egypt
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Eligibility overview
Sex: ALL
Age: 50 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * patients aged ≥ 50 years, with acute herpes zoster infection (rash duration \< 7 days) and moderate to severe pain. Exclusion Criteria: * Coagulation abnormalities * Pre-existing other pain syndrome or psychological disorders. * Severe hepatic, cardiovascular, or renal disorders. * Allergy to calcitonin.
Locations (1)
- Tanta, Gharbia Governorate, Egypt